In breast cancer, FTO mediates m6A demodifications in the 3’UTR of BCL2 interacting protein 3 (BNIP3) mRNA and induces its degradation, promoting breast cancer cell proliferation [270]. Here, BNIP3 is linked to breast carcinoma.